Retargeting R-Type Pyocins To Generate Novel Bactericidal Protein Complexes
- 15 June 2008
- journal article
- Published by American Society for Microbiology in Applied and Environmental Microbiology
- Vol. 74 (12), 3868-3876
- https://doi.org/10.1128/aem.00141-08
Abstract
R-type pyocins are high-molecular-weight bacteriocins that resemble bacteriophage tail structures and are produced by some Pseudomonas aeruginosa strains. R-type pyocins kill by dissipating the bacterial membrane potential after binding. The high-potency, single-hit bactericidal kinetics of R-type pyocins suggest that they could be effective antimicrobials. However, the limited antibacterial spectra of natural R-type pyocins would ultimately compromise their clinical utility. The spectra of these protein complexes are determined in large part by their tail fibers. By replacing the pyocin tail fibers with tail fibers of Pseudomonas phage PS17, we changed the bactericidal specificity of R2 pyocin particles to a different subset of P. aeruginosa strains, including some resistant to PS17 phage. We further extended this idea by fusing parts of R2 tail fibers with parts of tail fibers from phages that infect other bacteria, including Escherichia coli and Yersinia pestis , changing the killing spectrum of pyocins from P. aeruginosa to the bacterial genus, species, or strain that serves as a host for the donor phage. The assembly of active R-type pyocins requires chaperones specific for the C-terminal portion of the tail fiber. Natural and retargeted R-type pyocins exhibit narrow bactericidal spectra and thus can be expected to cause little collateral damage to the healthy microbiotae and not to promote the horizontal spread of multidrug resistance among bacteria. Engineered R-type pyocins may offer a novel alternative to traditional antibiotics in some infections.Keywords
This publication has 42 references indexed in Scilit:
- Antibacterial Efficacy of R-Type Pyocins towards Pseudomonas aeruginosa in a Murine Peritonitis ModelAntimicrobial Agents and Chemotherapy, 2008
- Molecular characterization of L-413C, a P2-related plague diagnostic bacteriophageVirology, 2008
- Efficacy of Bacteriophage Therapy against Gut-Derived Sepsis Caused by Pseudomonas aeruginosa in MiceAntimicrobial Agents and Chemotherapy, 2007
- SOS response promotes horizontal dissemination of antibiotic resistance genesNature, 2003
- Multiple sequence alignment with the Clustal series of programsNucleic Acids Research, 2003
- Characterization of Serracin P, a Phage-Tail-Like Bacteriocin, and Its Activity against Erwinia amylovora , the Fire Blight PathogenApplied and Environmental Microbiology, 2002
- Characterization of Enterocoliticin, a Phage Tail-Like Bacteriocin, and Its Effect on Pathogenic Yersinia enterocolitica StrainsApplied and Environmental Microbiology, 2001
- Antibiotic-Induced Release of Endotoxin A therapeutic ParadoxDrug Safety, 1995
- Sensitivity of Thermophilic Campylobacters to R-type Pyocines of Pseudomonas AeruginosaJournal of Medical Microbiology, 1982
- Bacteriophage-tail-like Particles Associated with Intra-species Killing of Proteus vulgarisJournal of General Virology, 1968